Fundamental role of nitric oxide in neuritogenesis of PC12h cells

British Journal of Pharmacology

Volumn 146, Issue 5, 2005, Pages 662-669

  Yamazaki, Matsumi ^a   Chiba, Kenzo ^a   Mohri, Tetsuro ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

cGMP; Extracellular signal regulated kinase; Neurite outgrowth; NO; PC12h cells; PKG

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 8 BROMO CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE INHIBITOR; KT 5823; LINSIDOMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; NITRIC ACID; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; SCAVENGER;

ANIMAL CELL; ARTICLE; CELL CLONE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME SUBSTRATE; NERVE CELL DIFFERENTIATION; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BLOTTING, WESTERN; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NEUROFILAMENT PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; PC12 CELLS; RATS;

EID: 27644448545     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706370     Document Type: Article

References (52)

1. AKAIKE, T., YOSHIDA, M., MIYAMOTO, Y., SATO, K., KOHNO, M., SASAMTO, K., MIYAZAKI, K., UEDA, S. & MAEDA, H. (1993). Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. Biochemistry, 32, 827-832.
2. waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 98, 12802-12807.
3. BROWN, D.A., LESIAK, K., REN, W.Y., STRZELECKI, K.L. & KHORLIN, A.A. (1999). Bicyclic monoterpene diols induce differentiation of S91 melanoma and PC12 pheochromocytoma cells by a cyclic guanosine-monophosphate-dependent pathway. Pigm. Cell Res., 12, 36-47.
4. BURSTElN, D.E., BLUMBERG, P.M. & GREENE, L.A. (1982). Nerve growth factor-induced neuronal differentiation of PC12 pheochromocytoma cells: lack of inhibition by a tumor promoter. Brain Res., 247, 115-119.
5. COWLEY, S., PATERSON, H., KEMP, P. & MARSHALL, C.J. (1994). Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77, 841-852.
6. DUDLEY, D.T., PANG, L., DECKER, S.J., BRIDGES, A.J. & SALTIEL, A.R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A., 92, 7686-7689.
7. FARINELLI, S.E., PARK, D.S. & GREENE, L.A. (1996). Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci., 16, 2325-2334.
8. FUKUDA, M., GOTOH, Y., TACHIBANE, T., DELL, K., HATTORI, S., YONEDA, Y. & NISHIDA, E. (1995). Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene. 11, 239-244.
9. GARG, U.C. & HASSID, A. (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest., 83, 1774-1777.
10. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
11. 2 receptor effects on neurite outgrowth in NG108-15 cells. Neuroendocrinology, 75, 70-81.
12. GOLD, B.G., MOBLEY, W.C. & MATHESON, S.F. (1991). Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J. Neurosci., 11, 943-955.
13. GOLDE, S., CHANDRAN, S., BROWN, G.C. & COMPSTON, A. (2002). Different pathways for iNOS-mediated toxicity in vitro dependent of neuronal maturation and NMDA receptor expression. J. Neurochem., 82, 269-282.
14. GREENE, L.A. & TISCHLER, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A., 73, 2424-2428.
15. HA, K.S., KIM, K.M., KWON, Y.G., BAI, S.K., NAM, W.D., YOO, Y.M., KIM, P.K.M., CHUNG, H.T., BILLIAR, T.R. & KIM, Y.M. (2003). Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J., 17, 1036-1047.
16. HATANAKA, H. (1981). Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line. Brain Res., 222, 225-233.
17. HINDLEY, S., JUURLINK, B.H.J., GYSBERS, J.W., MIDDLEMISS, P.J., HERMAN, M.A.R. & RATHBONE, M.P. (1997). Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J. Neurosci. Res., 47, 427-439.
18. HIRSCH, D.B., STEINER, J.P., DAWSON, T.M., MAMMEN, A., HAYEK, E. & SNYDER, S.H. (1993). Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr. Biol., 3, 749-754.
19. KATO, M., NISHINO, S., OHNO, M., FUKUYAMA, S., KITA, Y., HIRASAWA, Y., NAKANISHI, I., TAKASUGI, H. & SAKANE, K. (1996). New reagents for controlled release of nitric oxide: structure-stability relationships. Bioorg. Med. Chem. Lett., 6, 33-38.
20. KIM, S.O., XU, Y.J., KATZ, D. & PELECH, S. (2000). Cyclic GMP-dependent and -independent regulation of MAP kinases by sodium nitroprusside in isolated cardiomyocytes. Biochim. Biophys. Acta, 1496, 277-284.
21. KIM, Y.M., CHUNG, H.T., KIM, S.S., HAN, J.A., YOO, Y.M., KIM, K.M., LEE, G.H., YUN, H.Y., GREEN, A., LI, J., SIMMONS, R.L. & BILLIAR, T. (1999). Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci., 19, 6740-6747.
22. KITA, Y., HIRASAWA, Y., MAEDA, K., NISHINO, M. & YOSHIDA, K. (1994). Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol., 257, 123-130.
23. KITA, Y., OHKUBO, K., HIRASAWA, Y., KATAYAMA, Y., OHNO, M., NISHINO, S., KATO, M. & YOSHIDA, K. (1995). FR144420, a novel, slow, nitric oxide-releasing agent. Eur. J. Pharmacol., 275, 125-130.
24. KLEIN, S.D. & BRUNE, B. (2002). Heat-shock protein 70 attenuates nitric oxide-induced apoptosis in RAW macrophages by preventing cytochrome c release. Biochem. J., 362, 635-641.
25. KLINGE, J.M., TOPF, H.G., TRUSEN, B., RAUH, M., RASCHER, W. & DÖTSCH, J. (2003). Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Crit. Care Med., 31, 2010-2014.
26. KOWALUK, E.A., SETH, P. & FUNG, H.L. (1992). Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther., 262, 916-922.
27. LANDER, H.M., JACOVINA, A.T., DAVIS, R.J. & TAURAS, J.M. (1996). Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem., 271, 19705-19709.
28. LEE, M.K. & CLEVELAND, D.W. (1996). Neuronal intermediate filaments. Annu. Rev. Neurosci., 19, 187-217.
29. LINDENBAUM, M.H., CARBONETTO, S. & MUSHYNSKI, W.E. (1987). Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells. J. Biol. Chem., 262, 605-610.
30. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. MARSHALL, C.J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
32. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
33. OHKUMA, S. & KATSURA, M. (2001). Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Prog. Neurobiol., 64, 97-108.
34. PEUNOVA, N. & ENIKOLOPOV, G. (1995). Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature, 375, 68-73.
35. PHUNG, Y.T., BEKKER, J.M., HALLMARK, O.G. & BLACK, S.M. (1999). Both neuronal NO synthase and nitric oxide are required for PC12 cell differentiation: a cGMP independent pathway. Mol. Brain Res., 64, 165-178.
36. WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem., 272, 24002-24007.
37. 2-: implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic. Res. Commun., 10, 221-226.
38. SCHMIDT, H.H.H.W., LOHMANN, S.M. & WALTER, U. (1993). The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta, 1178, 153-175.
39. SCHONHOFF, C.M., BULSECO, D.A., BRANCHO, D.M., PARADA, L.F. & ROSS, A.H. (2001). The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells. J. Neurochem., 78, 631-639.
40. SCHULZ, S., CHINKERS, M. & GARBERS, D.L. (1989). The guanylate cyclase/receptor family of proteins. FASEB J., 3, 2026-2035.
41. SHEEHY, A.M., PHUNG, Y.T., RIEMER, R.K. & BLACK, S.M. (1997). Growth factor induction of nitric oxide synthase in rat pheochromocytoma cells. Mol. Brain Res., 52, 71-77.
42. TENG, K.K., ESPOSITO, D.K., SCHWARTZ, G.D., LANDER, H.M. & HEMPSTEAD, B.L. (1999). Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells. J. Biol. Chem., 274, 37315-37320.
43. THIPPESWARNY, T., MCKAY, J.S. & MORRIS, R. (2001). Bax and caspases are inhibited by endogenous nitric oxide in dorsal root ganglion neurons in vitro. Eur. J. Neurosci., 14, 1229-1236.
44. TINKER, J.H. & MICHENFELDER, J.D. (1976). Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology, 45, 40-54.
45. XU, B., CHIBBER, R., RUGGERIO, D., KOHNER, E., RITTER, J. & FERRO, A. (2003). Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J., 17, 1289-1291.
46. YAMAOKA, J., KABASHIMA, K., KAWANISHI, M., TODA, K. & MIYASHI, Y. (2002). Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide. Biochem. Biophys. Res. Commun., 291, 780-786.
47. YAMAZAKI, M., CHIBA, K., MOHRI, T. & HATANAKA, H. (2001). Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells. J. Neurochem., 79, 45-54.
48. YAMAZAKI, M., CHIBA, K., MOHRI, T. & HATANAKA, H. (2004). Cyclic GMP-dependent neurite outgrowth by genipin and nerve growth factor in PC12h cells. Eur. J. Pharmacol., 488, 35-43.
49. YAN, C.Y.I. & GREENE, L.A. (1998). Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. J. Neurosci., 18, 4042-4049.
50. YOSHIOKA, Y., YAMAMURO, A. & MAEDA, S. (2003). Nitric oxide at a low concentration protects murine macrophage RAW264 cells against nitric oxide-induced death via cGMP signaling pathway. Br. J. Pharmacol., 139, 28-34.
51. YUN, H.Y., DAWSON, V.L. & DAWSON, T.M. (1999). Glutamate-stimulated calcium activation of Ras/Erk pathway mediated by nitric oxide. Diabetes Res. Clin. Pract., 45, 113-115.
52. 2 receptor-mediated differentiation in PC12W cells. J. Neurochem., 85, 759-767.